Alcohol is a common part of social life for many people, but long-term heavy drinking can have serious effects on health. One ...

Researchers have shown they can detect cognitive decline related to heavy alcohol use even before clinical dementia symptoms appear, according to a study published in Alcohol: Clinical and ...

March 13 (Reuters) - Altimmune (ALT.O), opens new tab said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Accumulating scientific evidence and industry interest from Eli Lilly, Altimmune and startup Baseline Therapeutics is driving further research on the therapeutic potential of GLP-1 receptor agonists ...

Starting oral or injectable naltrexone at hospital discharge reduced heavy drinking in patients with alcohol use disorder. The hospital is an opportune setting for identifying and treating patients ...

Detailed price information for Adial Pharmaceuticals Inc (ADIL-Q) from The Globe and Mail including charting and trades.

DEAR DR. ROACH: What do you think of the Sinclair Method for dealing with an alcoholic? -- M.D. ANSWER: Naltrexone is approved for the treatment of alcohol use disorder under the Food and Drug ...

Alcohol awareness month in South Carolina is underway, and there are a lot of statsistics that back how much of a problem ...

A 2026 case report describes a 34-year-old man with obesity and alcohol use disorder whose semaglutide treatment for weight ...